XT
MRM

XTX Topco’s MEDIROM Healthcare Technologies MRM Stock Holding History

XTX Topco’s Portfolio MRM Stock Details MRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,066
Closed -$5.14K – 2878
2025
Q1 		$5.14K Buy
14,066
+508
+4% +$401 ﹤0.01% 2307
2024
Q4 		$14.2K Buy
+13,558
New +$33.8K ﹤0.01% 2097

Other funds holding MRM

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

XTX Topco's MRM Position: Q2 2025 in Review

XTX Topco sold out of MEDIROM Healthcare Technologies (MRM) in Q2 2025, closing a stake of 14,066 shares — an estimated $5.14K sold.

XTX Topco first reported a position in MRM in Q4 2024 and held it in 2 quarters. The position peaked at $14.2K in Q4 2024. 6 funds tracked by Wall St. Rank hold MRM as of Q2 2025.

  • XTX Topco reported no remaining MEDIROM Healthcare Technologies position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 14,066 MEDIROM Healthcare Technologies shares in Q2 2025, an estimated $5.14K.
  • XTX Topco first reported a position in MEDIROM Healthcare Technologies in Q4 2024 and held it in 2 quarters.
  • XTX Topco's MEDIROM Healthcare Technologies position peaked at $14.2K in Q4 2024.
  • 6 funds tracked by Wall St. Rank held MEDIROM Healthcare Technologies as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.